Search results
Results from the WOW.Com Content Network
Cover of Hare's Psychopathy Checklist-Revised (2nd ed., 2003). The Psychopathy Checklist or Hare Psychopathy Checklist-Revised, now the Psychopathy Checklist—revised (PCL-R), is a psychological assessment tool that is commonly used to assess the presence and extent of psychopathy in individuals—most often those institutionalized in the criminal justice system—and to differentiate those ...
The following diagnostic systems and rating scales are used in psychiatry and clinical psychology.This list is by no means exhaustive or complete. For instance, in the category of depression, there are over two dozen depression rating scales that have been developed in the past eighty years.
The General Health Questionnaire (GHQ) is a psychometric screening tool to identify common psychiatric conditions. [1] It has been translated and validated in at least two languages in addition to English, including Spanish [2] and Persian. [3] The latter used in different fields and generations. [4]
Pages in category "Personality disorders screening and assessment tools" The following 6 pages are in this category, out of 6 total. This list may not reflect recent changes .
Pages in category "Mental disorders screening and assessment tools" The following 84 pages are in this category, out of 84 total. This list may not reflect recent changes .
The Symptom Checklist-90-R (SCL-90-R) is a relatively brief self-report psychometric instrument (questionnaire) published by the Clinical Assessment division of the Pearson Assessment & Information group. It is designed to evaluate a broad range of psychological problems and symptoms of psychopathology.
The ASEBA was created by Thomas Achenbach in 1966 as a response to the Diagnostic and Statistical Manual of Mental Disorders (DSM-I). [3] This first edition of the DSM contained information on only 60 disorders; the only two childhood disorders considered were Adjustment Reaction of Childhood and Schizophrenic Reaction, Childhood Type.
The BSDS is a well validated diagnostic tool with a high sensitivity (0.76) and specificity (0.93) score. [2] It was also found to have a high Negative Predictive Value (NPV) of 0.87, suggesting that 87% of the patients who scored below 13 points on the BSDS were correctly identified as not having BD.